Adam Schayowitz sold $358K of Zymeworks (ZYME)

Executed Oct 9, disclosed Oct 9, the same day.

Value, as filed

$358K

13,832 sh × $25.85

Executed

Oct 9

the trade date, as filed

Disclosed

Oct 9

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

AS Adam Schayowitz EVP, Head of R&D profile →

Adam Schayowitz (EVP, Head of R&D) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Zymeworks Inc. (ZYME). The largest single filing was $358K of ZYME (13,832 sh × $25.85, as filed), executed Oct 9.

The name

ZYME Zymeworks Inc. ZYME · Healthcare · 26 filings in 24 months ticker →

Healthcare · Zymeworks Inc., a biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→